semaglutide fda approval mash Novo's Wegovy becomes first GLP-1 drug approved for Diabetes Dialogue: FDA Approves Semaglutide

It slows digestion, keeps you full longer, and turns down appetite signals

Online sellers are operating outside MHRA oversight

Early symptoms of NAION related vision loss can include: Loss of vision upon waking Dark area or shadow in vision Blurred vision Color vision loss Loss of contrast Light sensitivity Periocular eye pain Headache Ozempic, Mounjaro and Other Drugs Popular for Weight Loss Novo Nordisk research published in a popular medical journal The Lancet shows that the active ingredient in Ozempic may help a person lose about 15% of their body weight

Despite no longer being a general exclusion, an insurance provider may not include Ozempic or Wegovy on their prescription drug plan formulary

Regardless of your opinions of compounding GLP-1s and the durability of the business, those are impressive results